[{"title": "Precigen shares jump after US FDA approves first therapy for rare respiratory disease - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOb1NLR212RlJKakJ4cEVTTTRHNTR6OFB6cXU2NC0yYzdrV05IZVdCY29NR0xySm9CTVpZd21tYS01T3pHRnN6YXJUMUpKa2JyYktEa3hKQkxKUTI0ZDhUdGc0T01mbV9sb19pM2R4Qnkzc3dzMWtjRXJSeVFNcUJwOGxGZXZCcmZXRTVvamlUWVpHUl9xRk1sd2loQnpoRmI4UFpQNGM4Tk1iMHBiQ0pEVlNaeUxQMjVUS0dzU09JMC1vU0diYUQxU05Zd3BMMVZfNFhGdk1CNTdHMG43ZFE?oc=5\" target=\"_blank\">Precigen shares jump after US FDA approves first therapy for rare respiratory disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 15:34:49 GMT"}, {"title": "Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPWnp2NHdLN0VMZk1Ucmg2RThLd1pkT05WTW1JS0cydlVnandkYzZhVG1xOS1jcFUyajVhakhGVUh0LWk5V2tZWW5tc3pJWGIwaHJSUXdLRjdtdXJYeVp5d0p2LWdDbmZEajM2cVhKUXpXeUU3V1Z6dEJ3RzlNNjc3bjhMUXN1cFpjU3U0Y0VGYUprRzZaeFZrTTN1ay1Hbktp?oc=5\" target=\"_blank\">Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Fri, 15 Aug 2025 19:15:01 GMT"}, {"title": "Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMi2gJBVV95cUxOdndORDBKcUpBa2ZUR04zT0E4NWs0eWRaRkFhM3Naek1GZ1pQbTUyX3d2akFlU2xmdTlvMVFKQWRnRGhZeUt5MGJhMjVXZGY3T2Z2MlVfQk5MaF9vd2FiVENWRHYtSzZIYUctWHVuZXo4LUE5c0Z2cHdjZFpfVy0yOEZTR0I4aEFZdGZfWEw3UEJJbXBaYTFmdVkxVTJ4SnBIbGh1SkFBOXpBMTdkNlNONXA0WkRMbUYzVTJjclAyeUhnck1jbE5KRFFUMWc5S1lwOUNCSVBKa0FMNVcxUmNsYTRSczI5OUh5Q0Q2bG5GR2xHb09lNXhpRGF6cEstN2tZb3lnd01rbVZyMWtFdkZUSWxUcFdoV0RCeUJtYUNObHpzSjFGRUdOU0ZWSHdjal9hNzNFRk5LZ2VRX2Q1eVVyMF9YbWo2OGIzVU5kTVJCSGp3ajU4OTZVOWZR?oc=5\" target=\"_blank\">Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>", "publishedAt": "Fri, 15 Aug 2025 11:00:00 GMT"}, {"title": "Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos - Quiver Quantitative", "description": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNbVFqYkN5VTdGSkVsYzZVUU44dUdTbFR6bUs1TUFSVk4tRG1DT2xWc3U2a3VxYXFEMkdocDZKN19lV0Zla0pOampSR05WQU1vTDlYYmJCdjJLMW1sSTk2aDJqWWllTkxsbjRaY0UxNFAwUFpqUmd4dDR3WklrTk9Pa3gxNXRTVUs0UGRHUF81bDRNdHFXeGxaZWdIS2g2R0p4eGJMZXhRNA?oc=5\" target=\"_blank\">Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>", "publishedAt": "Fri, 15 Aug 2025 17:32:00 GMT"}, {"title": "Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why - Stocktwits", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxOc25aZ1dLTmd4U2tDcTdPNHlTb1lmOWZpeFVQVlM2aVhrcFVmS0ZrRVlKTmRITElnQjF2MFlrOU1nakFvdnkzUVdqUHFSSHdLX3lzcVg3amt3QUl5TlVkQ2VtSWg4b1VjcXBJWkVoeU5GdDlUcGpKcXJWeWpvaDRSUWtEYi1JZHJjOUFPZ2tuZFYtbzlCU0JsaWt3TE5PUm5KSzVkdnNMUFFTVWdkT0stSXdGa1ZhVHAySndadEpR?oc=5\" target=\"_blank\">Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocktwits</font>", "publishedAt": "Fri, 15 Aug 2025 12:01:00 GMT"}, {"title": "Precigen, Inc. Reports Q2 2025 Earnings and Strategic Focus - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVkExNkZfdGVWUlA2dXQ0OFBENWIyc0gyX2RyT2N0ZlFRZHRQYklrNy1fb3pMVFlkNGhNa3JjRnpEcHk2RWpyRVpRTnFvN0k0OUJzTG9oNDd0dHNPN2xrZ1JwdHZPeXJNWUVGR05xMl9UT0tibmR5dW5zVTFpeHZVZmJGMUFlNjJiZUFWdVJtSzZmVnZTREo1MEVSRk9OUHlhcjlPQ0R2R2lHYmpiZ1E?oc=5\" target=\"_blank\">Precigen, Inc. Reports Q2 2025 Earnings and Strategic Focus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Wed, 13 Aug 2025 04:09:06 GMT"}, {"title": "Precigen stock soars after FDA approves first RRP treatment - Investing.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNa3AwbkNxT0pjOV9ETnZMbEI5NzFmUU1SMHlZdS1fMnlmcFlCRWtPU1lKWkxMYVo3Q2Mxa3hNT2I0Ri1YaWpvSno5UHlRZ2ZpTUZ5Z05HbWFqYl91V25xYXg5Y1RNYlRaVFRnVlZaUVlQVVB0SjBIOVR2amVIcWV6a09TSkw1RUh1TDV4QUtDaG1vNWF3OWxlbTNsRFJMUXZ4MG9LMWJ0alhrNkxsd29kcHlPbWs2OE9ZWV81TlhR?oc=5\" target=\"_blank\">Precigen stock soars after FDA approves first RRP treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>", "publishedAt": "Fri, 15 Aug 2025 15:09:01 GMT"}, {"title": "Precigen\u2019s Remarkable Uptick: What Drives It? - StocksToTrade", "description": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE41UWVjbHVFSFh3ak1yUGRWQWs0aHhJUGw0T1k4MGNNNFhfX05yeG5OVlBtYXlKQkFWUlMzZHJkUHVWUHVfb0VTQzR2N0VMLVp4WHVPTXZIcnpZNkhsa1VYcjRadDVORFAxejduaGhEdWFnX00?oc=5\" target=\"_blank\">Precigen\u2019s Remarkable Uptick: What Drives It?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">StocksToTrade</font>", "publishedAt": "Fri, 15 Aug 2025 14:04:00 GMT"}, {"title": "A speedy FDA approval for Precigen\u2019s rare disease gene therapy - BioWorld MedTech", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNSEwzTVpzZDZuOVZRNGRRYk9wVi1GV1BpUVNLZ1Q0S25MUEVzMUZ5NU84MUxtT1hBcHExU0xRN3ExWHBnd21ZR0lpRWYtbThGU3Z6UUx2Yjg0cGdXeVZYbTR6dWRtMUk5ZmxLaFltM2cxVGtmbmtvVG5ER2lNcTE5N0xlSFBDWTVLczVoaW1RYjlnOVFPV3NMT3VhSHA0eGx1Sm5vWg?oc=5\" target=\"_blank\">A speedy FDA approval for Precigen\u2019s rare disease gene therapy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioWorld MedTech</font>", "publishedAt": "Fri, 15 Aug 2025 15:00:00 GMT"}, {"title": "US FDA approves Precigen's immunotherapy for rare respiratory disease - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNa0ZEMEppdGt5bFdsb0FEZUNHZmIwcXpNa3BvMmprVFZBaHNsWDZrTFd2R0VNVEJyRl9MczZ5QjhiNmZ5TnpQX29DR0Y2Qk0tWlBSd1JKTkdjMllsNmRFYXVvSzRwdk96dzVpZlRUVmRNb1lWR280RWNXcU1JNWxmR3pGbVZjUTN3QVVra1ppX195MlVWTHdCMVBiY0Vzc0dvenE0X2Mza25ILURXMnE5RmtCQ2pIeU52cGhhY2hGUllROUZERGUwYnNVakQ3alRMaGc?oc=5\" target=\"_blank\">US FDA approves Precigen's immunotherapy for rare respiratory disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Fri, 15 Aug 2025 14:01:40 GMT"}, {"title": "Why Is Precigen Stock Surging On Friday? - Precigen (NASDAQ:PGEN) - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOTFIwUmQ4RElvczAySGMzMDRDaTJqdjVWdExURkJjc05Idms4ME1PcWJSb3JoUUpEUzUxcW5MTHZuZWtqc0xWSTN0cXBza2MxRERIX3ZLTWlqYm1IRzRMZ2hDMTJjalk5R0p3R3VwY2pHOWtodmd3NjZfOEhYdWN3MjdjZ3BURW5JVFpPOFh5VWFSZw?oc=5\" target=\"_blank\">Why Is Precigen Stock Surging On Friday? - Precigen (NASDAQ:PGEN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Fri, 15 Aug 2025 13:48:12 GMT"}, {"title": "FDA Fully Approves Precigen\u2019s Papzimeos - Contract Pharma", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxOaEZ6U2dsekZUMENTZGpjcmd0a0ltblFMNDY5TnpJQ0ZLQVR3MDRPWGlfSFNCcmJqWmJ3VC1LeGZIRjRNWmRTRzgtc3RfVEp0amFNc2ZCMXJLdUYzTnFteElzMGRwUjUwMW83b0JzeXZRUFkySnFIeDNWeE5aZEdBOHJTeERvRlZjM1cxaQ?oc=5\" target=\"_blank\">FDA Fully Approves Precigen\u2019s Papzimeos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Contract Pharma</font>", "publishedAt": "Fri, 15 Aug 2025 13:13:38 GMT"}, {"title": "Undervalued Precigen: A Billion-Dollar Approval Waiting to Happen - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxQWDhpLTFpQlBXWEhxNjBMTXc2RDlMNEJ5ZTFPYW5WOE1oeFZnYXlsU2lYUV9KX2tFalRlcEZxek5VbU1sWUd1ZHdwa0xqeEtqdWJTWm80MDJkY2h2ZWh3MGJHSHRoRjdpazIzUEFPTTJDWXJMNGJEUWJmT3p0QmZQVDg4YzlGNEJuLVBtblBpVzdqaEhoUHl6YWFR?oc=5\" target=\"_blank\">Undervalued Precigen: A Billion-Dollar Approval Waiting to Happen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Fri, 15 Aug 2025 19:18:41 GMT"}, {"title": "Precigen stock surges on FDA approval (update) (PGEN:NASDAQ) - \u5bcc\u9014\u725b\u725b", "description": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQVEdka1o3ZFVYVW1sX3o1dHkwa04wNlpqbWlTT2pTa3lxb190VTdkWG5kb010dXVIdDdtMXA2RDhhX2NWSERTSms3UEQtYTdnSjJ4NEdxYWNpRVBBdEhUZWdVVlZYaE1XSnBoa0VOSkxQUXlLaUYxZU5UU1Z6WGNldDFWN1lpSnNNd0JoOUtESVJ3ekE?oc=5\" target=\"_blank\">Precigen stock surges on FDA approval (update) (PGEN:NASDAQ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">\u5bcc\u9014\u725b\u725b</font>", "publishedAt": "Fri, 15 Aug 2025 11:21:44 GMT"}, {"title": "Precigen announces full FDA approval of Papzimeos - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRVA1Z2ktZzRYX2U2Q2JTam9TRlBfVGVDQlVQVDhaSVZwQlFkNUN6MWNsX2VHeDUxakZsQk93dm41amF6cmk4MlBGbWthRjBTbjBGZjZmU3pKNjM3RW9IQXRuM3l2dEg5elgzYkFiUFBEZGJKSjdYY3NQbjg2Z0NoTThvVEFUeWVaLW11YkJLRUI0N3BOWVIwR2tSRW5oVEFYcEQ1ag?oc=5\" target=\"_blank\">Precigen announces full FDA approval of Papzimeos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Fri, 15 Aug 2025 11:24:25 GMT"}, {"title": "Precigen\u2019s Papzimeous Approval Allows US FDA CBER Director To Emphasize Flexibility - insights.citeline.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQRWpqakt2ai0yUGV5QmZLUE9FRzZHdXZvUENQcDVXMUluOXZwYTI2TmdWZUtMUTd6X2hBcXBTOWhXWnhaSWFrYkQ2T3JWSjBDRTRkMDA5alMwVnhTa3Jlc0poeHUxSzgydmdCQlh4U2JiTExwdElSMnNjRFhqTC1lZHRxZGw5eTl5S3kydXNKTzR1TDBGaWZMN1B3VmduaGFkZVRhT3FZQ0c5d0FvejRnS2N0QkpIOGxWaWk0VnhEZF9SMXBJZnRsaWh3NU5qZ2J2SWtUVGZWZnNBcGtfMUtkTWJrbjgwdnJUUExaSmtjVy1BU0hyZUhkYVNXaFBiZFdrV2NlckgzMlQ?oc=5\" target=\"_blank\">Precigen\u2019s Papzimeous Approval Allows US FDA CBER Director To Emphasize Flexibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>", "publishedAt": "Fri, 15 Aug 2025 22:40:21 GMT"}, {"title": "Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQLUxieEctQ0xPenBER2tpMWZVOFdMVnRYTFliU3pWZGJwZVpvdUxHWVlJbmV3b1VIYi1ld3UwZ2R3RHFFZ2ZDd1I4Wko4ZjZncldqZ0Z3eXRQWEJGVFNlQk12VzRKMWRKNzZsaHFjcXlid1RYZlFGQUIweGRuLVlyQmg5dnF0MnJlQnZXUmRwTWVqcFFzMWh5SGQ5OW9TVi1wanVUTERiSG9jOFI2TzFBQ1VfYl9TU0V1b3dXZ242N1BRSC1yUVBEbUFzWFlWaDFzZDQwSGRwWk8ydTRRa2c?oc=5\" target=\"_blank\">Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Fri, 15 Aug 2025 14:14:01 GMT"}, {"title": "FDA approves Precigen immunotherapy for respiratory papillomatosis - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNa1QzRzE1Q3dtakwtUnlzWFpuTTJXTUpRRm9XN1VPcjRMb0M2bzlObVlQLS1SYjBNVm9keTRKMVI3QUl5ZVVwMk8yYTNtTzhCMDNXRVVoMjR5c2NXaHd0Ulc1aGlJNmY0RWlIMUlkc3V3cTYwU1RJRF9zVlBuSVNGa0o3bTFNMGNTdVc0TGR1ZjA3bmd4UFVfRFRGMDdka1Y1clphRkJHd1NwSHdtOC1pTw?oc=5\" target=\"_blank\">FDA approves Precigen immunotherapy for respiratory papillomatosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Fri, 15 Aug 2025 09:08:43 GMT"}, {"title": "Precigen Shares on the Rise: Is Now the Time to Invest? - timothysykes.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE5QZDZaQl9EOWJjZk8zbzU2Q1FfR1FyWW42d3Yyei1CVzM0LUlra0pHVi16RGx3QjdTbHlJWHc3TVJueHRLbkhJOXdRX2Vxa05HeDVwZkFTUjBDNzEzSzJwUXBINjF2dWZSdWppa1lNZEtQTWVHdVA4?oc=5\" target=\"_blank\">Precigen Shares on the Rise: Is Now the Time to Invest?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">timothysykes.com</font>", "publishedAt": "Fri, 15 Aug 2025 13:19:00 GMT"}, {"title": "Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. - GuruFocus", "description": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxQX1lOT1lFeU83NjBmeVFhYWtiTHVxejA1X3pGWVA0a2RyWHlUa01nc3hiakVlOG1WVGtoNXNvSjA5dGlrMmlmdkpLODNpa1BfUUE3dlMxbXZtVk1STkU5aVdIVnp3ZWtWUWdhQWxzeGxKS19BbzF2RDVMU3ltQVRLRzBNeHJEczBYeDU4VHFKNU1qdGtXVWwwM2ZSeXNPV3hpRE1sT1B1TFNMYXBpVHowN09adWU?oc=5\" target=\"_blank\">Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>", "publishedAt": "Wed, 13 Aug 2025 12:31:27 GMT"}, {"title": "Precigen upgraded to Neutral from Underweight at JPMorgan - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxPdEdEbUJ6ZGlvN2FwVVFzSzUzLTd4RDMxb1Vpb0MyRWpySHdRT0xfdDh0dTRaUGxWX2lWTHNEeklWV2hSTUc4NkhGSEc0bTJlUUtPT2ZoajNfT0YwMTBTLTlGQm5iN0RaaVg4bnVNQnRUbllvRGsxa2FqZHZ0ci0tRWUwdVdmRjBXbDNuSXlwT1MzNUx1TGo1SG1hTjJrekV6a2FzcA?oc=5\" target=\"_blank\">Precigen upgraded to Neutral from Underweight at JPMorgan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Fri, 15 Aug 2025 11:06:15 GMT"}, {"title": "HC Wainwright Adjusts Price Target on Precigen to $8.50 From $6, Maintains Buy Rating - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOQmxqb2VVNGtRRzYwQ1kzTnA4Yk1JNFBzeDFhSW41N003NHU4ZUtEc3FrYlEyYV83YTY1TURZNUJmRWJGTXdJTHhYNS1ncTZHai1PN0NWbjhSdWNXaExOSVMxNWs5SUVEZEo4d3NBUExNcy1TUnY3ZWpXV0ppOGdQb3hKRmtCRGZBc0FiZl9sWHlGN1ljWnBRMGVGbThvdUJXUC1rSlpCRVQ3eUpGYmFoYnA3SGNlblFiMkFsOVpKdlZCakQzTkJjUmt1RnE3dG5h?oc=5\" target=\"_blank\">HC Wainwright Adjusts Price Target on Precigen to $8.50 From $6, Maintains Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Fri, 15 Aug 2025 12:13:43 GMT"}, {"title": "Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why By Stocktwits - Investing.com India", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbkdjRHpGMVY1WFJDRUZZMEtMTGoxZl84ZUc5d1JHZmh5ZGdMSEtRdUFCa3VVTzRYYm43d244OUwyREFMNGZxLWpaZVdNNVUyRWNDU0I5THF4QnluZHpoLURud21YZTJ2YUV0N1hjMGhtNUxhVF92ZVBXRkgyVk9rLVNHZWg3LVVzeWRKYVg3RDhHTl9iUVRGYUVURDVwRWMyODMtVF9wZEpQNktRRHo1YzhPX1BfV1p1ZlotaG1R?oc=5\" target=\"_blank\">Precigen Stock Shot Through The Roof On Friday Morning \u2013 Here\u2019s Why By Stocktwits</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com India</font>", "publishedAt": "Fri, 15 Aug 2025 11:58:13 GMT"}, {"title": "Has Precigen Inc. found a price floor - Market Risk Analysis & Consistent Profit Trading Strategies - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE4tcndXb0lpbjBCUm14YUtuREJVNUFuOGFnRm1JSUpjX1ZNYUk3SUgyTDFpSkJTckVDeUw3MDNlN3ZHUnVqSkVzVl85MEJjQS1MZ3VyV0tHVllqWGp0SV9JcVJDa2xRUy0ySTlvZmkxazJoRF8xYUJpaE9nZw?oc=5\" target=\"_blank\">Has Precigen Inc. found a price floor - Market Risk Analysis & Consistent Profit Trading Strategies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 07:09:22 GMT"}, {"title": "Short interest data insights for Precigen Inc. - 2025 Risk Factors & Expert Curated Trade Setups - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxQQW9OcnlMbDVKQjJ5ZGtPc0VzNlYtODl1YzVpSVUxWXZYUndQWUd5QXlDd0xwNjduTHp2bVVBTFh1SnJzWmFXQ1haYnUxVW9FODY2WC1sMlpxYmdlZVN1QVd0eGM5QWtvQ3lyYmE1UzdDVnJ4SVg1OWVCcDZJdDdMTy1ZTm9VREk?oc=5\" target=\"_blank\">Short interest data insights for Precigen Inc. - 2025 Risk Factors & Expert Curated Trade Setups</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 21:55:14 GMT"}, {"title": "Has Precigen Inc. found a price floor - July 2025 Rallies & Intraday High Probability Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTE8taG5qQnFYVGVNSHdVQUhSanVUaEtsbnV4ZHlELUVMQXZFZEwtZGJlQ3Jua3Q4Z281TVhZckg1b3I4X1NYRy1UYmlnWVM1STYtd0JlOEhzR2VfTHZWLXZoamJMalVFX1FIUHhSVE1rbVBDMVRzODBaZER3?oc=5\" target=\"_blank\">Has Precigen Inc. found a price floor - July 2025 Rallies & Intraday High Probability Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Thu, 14 Aug 2025 08:32:05 GMT"}, {"title": "Is Precigen Inc. stock poised for growth - July 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE5sVG5rb2VlWjVDTmthVWcwdERYSjhxUmZubHZZY0V1bGZpbmdBdmhrbzk2WFJ3cVJmR1JnSEZYaFQyMW9aLTFCODllMlVUd1RQeUQydThILXA0MUZOWHljYmExTU1ZbW9GTnktZWdrbjIzWlhWQWlV?oc=5\" target=\"_blank\">Is Precigen Inc. stock poised for growth - July 2025 EndofMonth & Precise Entry and Exit Recommendations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 21:40:31 GMT"}, {"title": "Precigen (NASDAQ:PGEN) Stock Price Up 7.5% After Earnings Beat - Defense World", "description": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxOUlIyelU3cVFIUjBxNlB3YU1xLXVhLUtwa0VwaDNiR1F5cDJWTXBDZE1mV0lRTUs1dHkxVW5kWlk3aVFMRlFGLUdQSnB4cV9xeFRPVzdTak5RX2FlbnJGdlo4N0JWRG1PWjlfTnlybS1VcjdaWmV1cU9GT042ZnRnN2V4cldXY2c1NkEtYW1aSnFpblBFdmF4TmRILTBvYmFwR1h4YUN3?oc=5\" target=\"_blank\">Precigen (NASDAQ:PGEN) Stock Price Up 7.5% After Earnings Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Defense World</font>", "publishedAt": "Thu, 14 Aug 2025 06:52:51 GMT"}]